INTERACTION OF RAT MONOCLONAL-ANTIBODIES WITH HUMAN KILLER CELLS (K-CELLS)

INTERACTION OF RAT MONOCLONAL-ANTIBODIES WITH HUMAN KILLER CELLS (K-CELLS)

Detalhes bibliográficos
Main Authors:	Hale, G, Clark, M, Waldmann, H
Formato:	Journal article
Publicado em:	1984

Registos relacionados

Interaction of rat monoclonal antibodies with human killer cells.
Por: Clark, M, et al.
Publicado em: (1985)

Therapeutic potential of rat monoclonal antibodies: isotype specificity of antibody-dependent cell-mediated cytotoxicity with human lymphocytes.
Por: Hale, G, et al.
Publicado em: (1985)

Advantages of rat monoclonal antibodies.
Por: Clark, M, et al.
Publicado em: (1983)

Identification of cells of the human mononuclear phagocyte system with rat monoclonal antibodies.
Por: Aqel, N, et al.
Publicado em: (1987)

IDENTIFICATION OF CELLS OF THE HUMAN MONONUCLEAR PHAGOCYTE SYSTEM WITH RAT MONOCLONAL-ANTIBODIES
Por: Aqel, N, et al.
Publicado em: (1987)

MONOCLONAL-ANTIBODIES TO HEMATOPOIETIC-CELLS
Por: Waldmann, H, et al.
Publicado em: (1982)

Monoclonal antibody H9/25 reacts with functional subsets of T and B cells: killer, killer precursor and plaque-forming cells.
Por: Takei, F, et al.
Publicado em: (1980)

INTERACTION OF MONOCLONAL-ANTIBODIES WITH THE IMMUNE-SYSTEM
Por: Clark, M, et al.
Publicado em: (1986)

Rat monoclonal antibodies for bone marrow transplantation--the CAMPATH series.
Por: Waldmann, H, et al.
Publicado em: (1985)

RAT MONOCLONAL-ANTIBODIES FOR BONE-MARROW TRANSPLANTATION (BMT) - THE CAMPATH SERIES
Por: Waldmann, H, et al.
Publicado em: (1985)

Reactivity of rat monoclonal antibody CAMPATH-1 with human leukaemia cells and its possible application for autologous bone marrow transplantation.
Por: Hale, G, et al.
Publicado em: (1985)

T-cell killing of target cells induced by hybrid antibodies: comparison of two bispecific monoclonal antibodies.
Por: Clark, MR, et al.
Publicado em: (1987)

Tolerance to rat monoclonal antibodies. Implications for serotherapy.
Por: Benjamin, R, et al.
Publicado em: (1986)

Manipulation of T-cell responses with monoclonal antibodies.
Por: Waldmann, H
Publicado em: (1989)

HUMANIZED MONOCLONAL-ANTIBODY THERAPY IN RHEUMATOID-ARTHRITIS
Por: Isaacs, J, et al.
Publicado em: (1992)

Humanized monoclonal antibody treatment in rheumatoid arthritis.
Por: Kyle, V, et al.
Publicado em: (1991)

Specificity of monoclonal antibody Campath-1.
Por: Hale, G, et al.
Publicado em: (1988)

Purging in auto- and allografts: monoclonal antibodies which use human complement and other natural effector mechanisms.
Por: Cobbold, S, et al.
Publicado em: (1990)

Purging in auto- and allografts: monoclonal antibodies which use human complement and other natural effector mechanisms.
Por: Cobbold, S, et al.
Publicado em: (1990)

A therapeutic human IgG4 monoclonal antibody that depletes target cells in humans.
Por: Isaacs, J, et al.
Publicado em: (1996)

Anti-globulin responses to rat and humanized CAMPATH-1 monoclonal antibody used to treat transplant rejection.
Por: Rebello, P, et al.
Publicado em: (1999)

Monoclonal antibodies for immunosuppression.
Por: Waldmann, H, et al.
Publicado em: (1988)

Pilot study of CAMPATH-1, a rat monoclonal antibody that fixes human complement, as an immunosuppressant in organ transplantation.
Por: Hale, G, et al.
Publicado em: (1986)

CAMPATH-1 monoclonal antibodies in bone marrow transplantation.
Por: Hale, G, et al.
Publicado em: (1994)

MONOCLONAL-ANTIBODIES FOR CONDITIONING PRIOR TO MARROW TRANSPLANTATION
Por: Hale, G, et al.
Publicado em: (1989)

RAT MONOCLONAL-ANTIBODIES TO PREVENT G-VS-H AND H-VS-G REACTIONS IN BONE-MARROW TRANSPLANTATION
Por: Waldmann, H, et al.
Publicado em: (1986)

Monoclonal-antibody therapy in systemic vasculitis.
Por: Mathieson, P, et al.
Publicado em: (1990)

HUMANIZED MONOCLONAL-ANTIBODY THERAPY FOR SYSTEMIC VASCULITIS
Por: Lockwood, C, et al.
Publicado em: (1993)

Appropriate targets for monoclonal antibodies in the induction of transplantation tolerance.
Por: Waldmann, H, et al.
Publicado em: (2001)

Removal of T cells from bone marrow for transplantation: a monoclonal antilymphocyte antibody that fixes human complement.
Por: Hale, G, et al.
Publicado em: (1983)

Human monoclonal antibodies: the residual challenge of antibody immunogenicity.
Por: Waldmann, H
Publicado em: (2014)

BIOLOGICAL EFFECTS OF A HUMAN IGG4 MONOCLONAL-ANTIBODY IN-VIVO
Por: Isaacs, J, et al.
Publicado em: (1995)

Therapeutic potential of monoclonal antibodies to the leucocyte common antigen.
Por: Bindon, C, et al.
Publicado em: (1985)

Therapeutic potential of monoclonal antibodies to the leukocyte-common antigen. Synergy and interference in complement-mediated lysis.
Por: Bindon, C, et al.
Publicado em: (1985)

Treatment of refractory Wegener's granulomatosis with humanized monoclonal antibodies.
Por: Lockwood, C, et al.
Publicado em: (1996)

HUMANIZED MONOCLONAL-ANTIBODY (MAB) THERAPY FOR WEGENERS GRANULOMATOSIS (WG)
Por: Lockwood, C, et al.
Publicado em: (1995)

EFFECTS OF MONOCLONAL-ANTIBODIES OF THE CAMPATH SERIES INVIVO - REQUIREMENTS FOR EFFECTIVE ANTIBODY THERAPY
Por: Dyer, M, et al.
Publicado em: (1988)

Importance of antigen specificity for complement-mediated lysis by monoclonal antibodies.
Por: Bindon, C, et al.
Publicado em: (1988)

Identification of macrophages and smooth muscle cells in human atherosclerosis using monoclonal antibodies.
Por: Aqel, N, et al.
Publicado em: (1985)

Detection of monoclonal antibodies against cell surface antigens: the use of antiglobulins coupled to red blood cells.
Por: Clark, MR, et al.
Publicado em: (1984)